Hoofd- en hals tumoren: hyperthermie aanvullend op bestraling geeft 36,2 procent meer complete remissies dan alleen bestraling bij tumoren in het hoofd- en halsgebied. Artikel update 22 maart 2012

20 september 2011: Bron: J Cancer Res Ther. 2010 Oct-Dec;6(4):492-6.

Wanneer patienten met hoofd- en halstumoren naast bestraling - radiotherapie ook hyperthermie krijgen blijkt maar liefst 36% meer patienten (42.4% versus 78.6%) in een totale remissie te komen in vergelijking met alleen bestralen - radiotherapie. Dat is het resultaat uit een gerandomiseerde studie bij totaal 56 patienten met hoofd- halstumoren. Opnieuw bewijst dus hyperthermie zijn grote waarde. Hier het abstract van de studie maar als u hier klikt kunt u het volledige studierapport met grafieken enz. gratis inzien. Onderaan staat ook referentielijst.

Radiofrequency (RF) based heating (hyperthermia) and radical radiation of head and neck cancers is better than in RT alone group. HT should be considered as a valid option wherever the facility for Hyperthermia is available

J Cancer Res Ther. 2010 Oct-Dec;6(4):492-6.

Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial.

Huilgol NG, Gupta S, Sridhar CR.

Source

Department of Radiation Oncology, Dr. Balabhai Nanavati Hospital, Mumbai, India. nagrajhuilgol@gmail.com

Abstract

BACKGROUND:

Head and neck cancer is the leading cause of male mortality due to cancer in India. Surgery, radiation alone or in combination has been the backbone of treatment strategies. Chemo-radiation has emerged as the standard of care in most types of head and neck cancer. This strategy has the advantage of maintaining both structure and functions, albeit with increased acute and delayed side effects. Radiation with hyperthermia can achieve the same objective without additional toxicities.

MATERIALS AND METHODS:

A total of 56 patients were randomized to radiation therapy (RT) alone or RT-hyperthermia (RT-HT) arm. Twenty-six patients were included in RT alone arm and 28 patients in the RT-HT arm. Both groups were evenly matched for age, sex, and stage. Patients in both the arms received radiation to a dose of 66-70 Gy in 6.5-7 weeks. Patients in the study group received weekly HT. HT was started after impedance matching to last for 30 minutes.

RESULTS:

Complete response was seen in 42.4% of RT alone group compare to 78.6% in the HT group. The difference was statistically significant ( < 0.05). Kaplan-Meir analysis of survival also showed a significant improvement in favor of RT-HT. No dose limiting thermal burns and excessive mucosal or thermal toxicity were recorded.

CONCLUSION:

Radiofrequency (RF) based heating and radical radiation of head and neck cancers is better than in RT alone group. HT should be considered as a valid option wherever the facility for HT is available. This report should infuse greater confidence in radiation Oncologists to practice HT as an adjuvant treatment modality.

PMID:
21358087
[PubMed - indexed for MEDLINE]
Read the full study report here
References   Top

 

1. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.   Back to cited text no. 1
    
2. Pignon JP, le Maître A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14.   Back to cited text no. 2
    
3. Van der Zee J, González González D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-25.  Back to cited text no. 3
    
4. Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 1988;15:13-24.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5. Issels RD. HT adds to chemotherapy. Eur J cancer 2008; 44(17):2546-54.  Back to cited text no. 5
    
6. Raaphorst G. Fundamental aspects of HT biology. In: Fields HJ, editor. An introduction to the practical aspects of clinical HT. London: Taylor and Francis; 1990. p. 10-54.  Back to cited text no. 6
    
7. Roti Roti JL. Heat-induced alterations of nuclear protein associations and their effects on DNA repair and replication. Int J Hyperthermia 2007;23:3.  Back to cited text no. 7
[PUBMED]    
8. Lepock JR. Role of nuclear protein denaturation and aggregation in thermal radiosensitization. Int J Hyperthermia 2004;20:115.  Back to cited text no. 8
[PUBMED]  [FULLTEXT]  
9. Vidair CA, Dewey WC. Division-associated and division-independent hyperthermic cell death: Comparison with other cytotoxic agents. Int J Hyperthermia 1991;7:51-60.  Back to cited text no. 9
[PUBMED]    
10. Ressel A, Weiss C, Feyerabend T. Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival. Int J Radiat Oncol Biol Phys 2001;49:1119-25.  Back to cited text no. 10
[PUBMED]  [FULLTEXT]  
11. Iliakis G, Wu W, Wang M. DNA double strand break repair inhibition as a cause of heat radiosensitization: Re-evaluation considering backup pathways of NHEJ. Int J Hyperthermia 2008;24:17.  Back to cited text no. 11
[PUBMED]  [FULLTEXT]  
12. Gainal US. OH OJ, Issels RD, Wesslowski R. Clinical Results of quality assured HT, 48-57 in HT in oncology principles and theraupeutic outlook. Uni - Med, 2010.  Back to cited text no. 12
    
13. De Hass- Kock DF, Buijsen J, Pijls- Johannesma M. Concomitant HT and radiation therapy for treating locally advanced rectal cancer. Cochrane Data base syst Rev 2009;CD006269.  Back to cited text no. 13